Controlling love: the ethics and desirability of using 'love drugs'
Recent research in neurochemistry has shown there to be a number of chemical compounds that are implicated in the patterns of lust, attraction, and attachment that undergird romantic love. For example, there is evidence that the phenomenon of attachment is associated with the action of oxytocin and...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Cambridge
Cambridge University Press
2022
|
Schlagworte: | |
Online-Zugang: | BSB01 UBG01 Volltext |
Zusammenfassung: | Recent research in neurochemistry has shown there to be a number of chemical compounds that are implicated in the patterns of lust, attraction, and attachment that undergird romantic love. For example, there is evidence that the phenomenon of attachment is associated with the action of oxytocin and vasopressin. There is therefore some reason to suppose that patterns of lust, attraction, and attachment could be regulated via manipulation of these substances in the brain: in other words, by their use as 'love drugs'. A growing bioethical literature asks searching questions about this prospect, and especially about the use of such drugs to enhance or reignite attachment in flagging relationships. This Element examines some of the central arguments on the topic, and sounds a note of caution. It urges that there are reasons to think the states of attachment produced or facilitated by the use of such drugs would not be desirable |
Beschreibung: | Title from publisher's bibliographic system (viewed on 02 Sep 2022) |
Beschreibung: | 1 Online-Ressource (60 Seiten) |
ISBN: | 9781009299060 |
DOI: | 10.1017/9781009299060 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV048501557 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 221007s2022 |||| o||u| ||||||eng d | ||
020 | |a 9781009299060 |c Online |9 978-1-00-929906-0 | ||
024 | 7 | |a 10.1017/9781009299060 |2 doi | |
035 | |a (ZDB-20-CBO)CR9781009299060 | ||
035 | |a (OCoLC)1347225052 | ||
035 | |a (DE-599)BVBBV048501557 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-473 | ||
082 | 0 | |a 615.78 | |
100 | 1 | |a Herissone-Kelly, Peter |d ca. 20./21. Jh. |0 (DE-588)133506029 |4 aut | |
245 | 1 | 0 | |a Controlling love |b the ethics and desirability of using 'love drugs' |c Peter Herissone-Kelly |
264 | 1 | |a Cambridge |b Cambridge University Press |c 2022 | |
300 | |a 1 Online-Ressource (60 Seiten) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Title from publisher's bibliographic system (viewed on 02 Sep 2022) | ||
520 | |a Recent research in neurochemistry has shown there to be a number of chemical compounds that are implicated in the patterns of lust, attraction, and attachment that undergird romantic love. For example, there is evidence that the phenomenon of attachment is associated with the action of oxytocin and vasopressin. There is therefore some reason to suppose that patterns of lust, attraction, and attachment could be regulated via manipulation of these substances in the brain: in other words, by their use as 'love drugs'. A growing bioethical literature asks searching questions about this prospect, and especially about the use of such drugs to enhance or reignite attachment in flagging relationships. This Element examines some of the central arguments on the topic, and sounds a note of caution. It urges that there are reasons to think the states of attachment produced or facilitated by the use of such drugs would not be desirable | ||
650 | 4 | |a Psychotropic drugs | |
650 | 4 | |a Medical ethics | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-00-929905-3 |
856 | 4 | 0 | |u https://doi.org/10.1017/9781009299060 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-20-CBO | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-033878827 | ||
966 | e | |u https://doi.org/10.1017/9781009299060 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1017/9781009299060 |l UBG01 |p ZDB-20-CBO |q UBG_PDA_CBO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804184471052746752 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Herissone-Kelly, Peter ca. 20./21. Jh |
author_GND | (DE-588)133506029 |
author_facet | Herissone-Kelly, Peter ca. 20./21. Jh |
author_role | aut |
author_sort | Herissone-Kelly, Peter ca. 20./21. Jh |
author_variant | p h k phk |
building | Verbundindex |
bvnumber | BV048501557 |
collection | ZDB-20-CBO |
ctrlnum | (ZDB-20-CBO)CR9781009299060 (OCoLC)1347225052 (DE-599)BVBBV048501557 |
dewey-full | 615.78 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.78 |
dewey-search | 615.78 |
dewey-sort | 3615.78 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
discipline_str_mv | Medizin |
doi_str_mv | 10.1017/9781009299060 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02449nmm a2200397zc 4500</leader><controlfield tag="001">BV048501557</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">221007s2022 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009299060</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-00-929906-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/9781009299060</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781009299060</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1347225052</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048501557</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-473</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.78</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Herissone-Kelly, Peter</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="0">(DE-588)133506029</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Controlling love</subfield><subfield code="b">the ethics and desirability of using 'love drugs'</subfield><subfield code="c">Peter Herissone-Kelly</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (60 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 02 Sep 2022)</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Recent research in neurochemistry has shown there to be a number of chemical compounds that are implicated in the patterns of lust, attraction, and attachment that undergird romantic love. For example, there is evidence that the phenomenon of attachment is associated with the action of oxytocin and vasopressin. There is therefore some reason to suppose that patterns of lust, attraction, and attachment could be regulated via manipulation of these substances in the brain: in other words, by their use as 'love drugs'. A growing bioethical literature asks searching questions about this prospect, and especially about the use of such drugs to enhance or reignite attachment in flagging relationships. This Element examines some of the central arguments on the topic, and sounds a note of caution. It urges that there are reasons to think the states of attachment produced or facilitated by the use of such drugs would not be desirable</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical ethics</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-00-929905-3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/9781009299060</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033878827</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009299060</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009299060</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">UBG_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV048501557 |
illustrated | Not Illustrated |
index_date | 2024-07-03T20:44:40Z |
indexdate | 2024-07-10T09:39:51Z |
institution | BVB |
isbn | 9781009299060 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033878827 |
oclc_num | 1347225052 |
open_access_boolean | |
owner | DE-12 DE-473 DE-BY-UBG |
owner_facet | DE-12 DE-473 DE-BY-UBG |
physical | 1 Online-Ressource (60 Seiten) |
psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO UBG_PDA_CBO |
publishDate | 2022 |
publishDateSearch | 2022 |
publishDateSort | 2022 |
publisher | Cambridge University Press |
record_format | marc |
spelling | Herissone-Kelly, Peter ca. 20./21. Jh. (DE-588)133506029 aut Controlling love the ethics and desirability of using 'love drugs' Peter Herissone-Kelly Cambridge Cambridge University Press 2022 1 Online-Ressource (60 Seiten) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 02 Sep 2022) Recent research in neurochemistry has shown there to be a number of chemical compounds that are implicated in the patterns of lust, attraction, and attachment that undergird romantic love. For example, there is evidence that the phenomenon of attachment is associated with the action of oxytocin and vasopressin. There is therefore some reason to suppose that patterns of lust, attraction, and attachment could be regulated via manipulation of these substances in the brain: in other words, by their use as 'love drugs'. A growing bioethical literature asks searching questions about this prospect, and especially about the use of such drugs to enhance or reignite attachment in flagging relationships. This Element examines some of the central arguments on the topic, and sounds a note of caution. It urges that there are reasons to think the states of attachment produced or facilitated by the use of such drugs would not be desirable Psychotropic drugs Medical ethics Erscheint auch als Druck-Ausgabe 978-1-00-929905-3 https://doi.org/10.1017/9781009299060 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Herissone-Kelly, Peter ca. 20./21. Jh Controlling love the ethics and desirability of using 'love drugs' Psychotropic drugs Medical ethics |
title | Controlling love the ethics and desirability of using 'love drugs' |
title_auth | Controlling love the ethics and desirability of using 'love drugs' |
title_exact_search | Controlling love the ethics and desirability of using 'love drugs' |
title_exact_search_txtP | Controlling love the ethics and desirability of using 'love drugs' |
title_full | Controlling love the ethics and desirability of using 'love drugs' Peter Herissone-Kelly |
title_fullStr | Controlling love the ethics and desirability of using 'love drugs' Peter Herissone-Kelly |
title_full_unstemmed | Controlling love the ethics and desirability of using 'love drugs' Peter Herissone-Kelly |
title_short | Controlling love |
title_sort | controlling love the ethics and desirability of using love drugs |
title_sub | the ethics and desirability of using 'love drugs' |
topic | Psychotropic drugs Medical ethics |
topic_facet | Psychotropic drugs Medical ethics |
url | https://doi.org/10.1017/9781009299060 |
work_keys_str_mv | AT herissonekellypeter controllinglovetheethicsanddesirabilityofusinglovedrugs |